These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 638321)
41. 7th International Conference on Peripheral Dopamine. Dublin, Ireland, 3-5 August 1998. Proceedings and abstracts. Clin Exp Pharmacol Physiol Suppl; 1999 Apr; 26():S1-76. PubMed ID: 10484671 [No Abstract] [Full Text] [Related]
42. A marking method for stimulating electrode locations. Tatton W; Crapper D Electroencephalogr Clin Neurophysiol; 1970 Dec; 29(6):621-2. PubMed ID: 4098586 [No Abstract] [Full Text] [Related]
43. In vivo and in vitro dopaminergic effects of three ergoline fragments. Koons JC; Long JP; Cannon JG Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):180-5. PubMed ID: 6527705 [TBL] [Abstract][Full Text] [Related]
45. Pharmacology of bromocriptine in health and disease. Mehta AE; Tolis G Drugs; 1979 May; 17(5):313-25. PubMed ID: 222567 [TBL] [Abstract][Full Text] [Related]
47. The reversal by metoclopramide of apomorphine-induced inhibition of responses to stimulation of the cardioaccelerator nerves in the cat. Tuncer M Indian J Physiol Pharmacol; 1984; 28(1):15-20. PubMed ID: 6490125 [TBL] [Abstract][Full Text] [Related]
48. Analysis of the effects of bromocriptine on blood pressure and sympathetic nerve function. Lokhandwala MF Eur J Pharmacol; 1979 Jun; 56(3):253-6. PubMed ID: 477721 [TBL] [Abstract][Full Text] [Related]
49. Dopaminergic inhibition of sympathetic activity in the cat. Dóda M; György L Pol J Pharmacol Pharm; 1985; 37(3):397-404. PubMed ID: 4070081 [TBL] [Abstract][Full Text] [Related]
50. Evaluation of the central and peripheral components for induction of postural hypotension by guanethidine, clonidine, dopamine2 receptor agonists and 5-hydroxytryptamine1A receptor agonists. Park KH; Long JP; Cannon JG J Pharmacol Exp Ther; 1991 Dec; 259(3):1221-30. PubMed ID: 1762069 [TBL] [Abstract][Full Text] [Related]
51. The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine). Del Pozo E; Del Re RB; Varga L; Friesen H J Clin Endocrinol Metab; 1972 Nov; 35(5):768-71. PubMed ID: 4672297 [No Abstract] [Full Text] [Related]
52. Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons. Corrodi H; Fuxe K; Hökfelt T; Lidbrink P; Ungerstedt U J Pharm Pharmacol; 1973 May; 25(5):409-12. PubMed ID: 4146398 [No Abstract] [Full Text] [Related]
53. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA. Johnson AM; Loew DM; Vigouret JM Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193 [TBL] [Abstract][Full Text] [Related]
54. Further evidence for dopaminoceptors in the vas deferens [proceedings]. Tayo FM; Osuide G Br J Pharmacol; 1977 Mar; 59(3):511P-512P. PubMed ID: 843747 [No Abstract] [Full Text] [Related]
55. Dopamine receptor mediated inhibition by bromocriptine of accelerator nerve stimulation effects in the pithed cat [proceedings]. Scholtysik G; Berde B Br J Pharmacol; 1978 Mar; 62(3):379P. PubMed ID: 638321 [No Abstract] [Full Text] [Related]